Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Globus Medical has completed its acquisition of Nevro, broadening its market presence in musculoskeletal solutions.

Learn more about whether Globus Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Learn more about whether Globus Medical, Inc. or NovoCure Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into ...